Be part of the knowledge.™

Rare and Orphan Diseases

5

LikeLikedUnlike

Episodes 1-15 of 17

The Role of IL-6 in PMR: From Disease Pathogenesis to Treatment
Medical Industry Feature
The Role of IL-6 in PMR: From Disease Pathogenesis to Treatment
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Adam Brown, MD
  Peer
- Alexa Meara, MD
  Peer
Platelet Perspectives: Analysing Phase III Data
Medical Industry Feature
Platelet Perspectives: Analysing Phase III Data
- Shivi Jain, MD
  Peer
- Scott Kolodny
  Peer
Ig Therapy: A Cornerstone of Treatment for CIDP
Medical Industry Feature
Ig Therapy: A Cornerstone of Treatment for CIDP
Newborn Gene Sequencing: Expanding Early Detection of Treatable Diseases
Medical Industry Feature
Newborn Gene Sequencing: Expanding Early Detection of Treatable Diseases
- Jordan Orange, MD, PhD
  Peer
- Joshua Milner, MD
  Peer
- Eric Silver, MD
  Peer
- Steven Lobritto, MD
  Peer
Gene Therapy for Hemophilia B: Real-World Perspectives from an HCP and Patient
Medical Industry Feature
Gene Therapy for Hemophilia B: Real-World Perspectives from an HCP and Patient
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Doris Quon, MD, PhD
  Peer
- Greg H., Patient Speaker
  Peer
Frontline Consolidation in B-ALL: Expert Insights on the Role of Blinatumomab
Medical Industry Feature
Frontline Consolidation in B-ALL: Expert Insights on the Role of Blinatumomab
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Aaron Logan, MD, PhD
  Peer
advertisement
Asparaginase Therapy in Patients with ALL/LBL
Medical Industry Feature
Asparaginase Therapy in Patients with ALL/LBL
- Jennifer Caudle, DO
  Peer
- Leidy Isenalumhe, MD, MS
  Peer
Decoding Gene Therapy for Hemophilia B: Expert Insights on Common Myths
Medical Industry Feature
Decoding Gene Therapy for Hemophilia B: Expert Insights on Common Myths
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Kim Phelan
  Peer
- Guy Young, MD
  Peer
Evaluating First-Line Therapy for Acute
Graft-Versus-Host Disease
Medical Industry Feature
Evaluating First-Line Therapy for Acute
Graft-Versus-Host Disease
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Yi Bin Chen, MD
  Peer
- Olaf Penack, MD
  Peer
Upgrade Your Adult Patients’ IgAN Treatment
Medical Industry Feature
Upgrade Your Adult Patients’ IgAN Treatment
- Abdul Abdellatif, MD, FASN
  Peer
- Omaima Degani, MD
  Peer
CV Risk in Patients with Narcolepsy: See the Data
Medical Industry Feature
CV Risk in Patients with Narcolepsy: See the Data
Managing the Complexities of Acute Graft-Versus-Host Disease: Current Challenges and Unmet Needs
Medical Industry Feature
Managing the Complexities of Acute Graft-Versus-Host Disease: Current Challenges and Unmet Needs
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Miguel-Angel Perales, MD
  Peer
- Anna Sureda, MD, PhD
  Peer
advertisement
Navigating CLL Treatment: Patient Preferences and Shared Decision-Making
Medical Industry Feature
Navigating CLL Treatment: Patient Preferences and Shared Decision-Making
- Matt Birnholz, MD
  Peer
- Alexey Danilov, MD, PhD
  Peer
- Brian Koffman, MDCM
  Peer
The CLL Patient Journey: From Diagnosis to Initial Treatment
Medical Industry Feature
The CLL Patient Journey: From Diagnosis to Initial Treatment
- Matt Birnholz, MD
  Peer
- Alexey Danilov, MD, PhD
  Peer
- Brian Koffman, MDCM
  Peer
Advancements in Understanding ALS Treatment
Medical Industry Feature
Advancements in Understanding ALS Treatment
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Gustavo Suarez Zambrano, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended